SALEM, NH--(Marketwired - Jun 15, 2016) - ProPhotonix Limited (OTC PINK: STKR) (LSE: PPIX) (LSE: PPIR)
OTC: STKR; AIM: PPIX
ProPhotonix Receives $1.1 million Order
(Salem, New Hampshire, June 15, 2016) ProPhotonix Limited (OTC: STKR and London Stock Exchange - AIM: PPIX) announces the
receipt of a $1.1 million order for laser modules from one of its largest customers. Deliveries for this order are currently
scheduled for the remainder of 2016 and early 2017.
Commenting on the order, Jeremy Lane, Managing Director of ProPhotonix Limited, laser business unit said, "We are delighted to
receive this order from our customer. We have been collaborating with them on this product design for their application for more
than a year, and this order represents a joint success for both of our companies. Production fulfilment for this customer began
at the end of 2015 and has ramped up dramatically."
About ProPhotonix
ProPhotonix Limited, headquartered in Salem, New Hampshire, is a high technology designer and manufacturer of diode-based
laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes
premium diodes for Ushio (formerly Oclaro), Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including
the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S.,
Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at
www.prophotonix.com
Cautionary Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including without
limitation, those with respect to ProPhotonix's goals, plans and strategies set forth herein are forward-looking statements. The
following important factors and uncertainties, among others, could cause actual results to differ materially from those described
in these forward-looking statements: uncertainty that cash balances may not be sufficient to allow ProPhotonix to meet all of its
business goals; uncertainty that ProPhotonix's new products will gain market acceptance; the risk that delays and unanticipated
expenses in developing new products could delay the commercial release of those products and affect revenue estimates; the risk
that one of our competitors could develop and bring to market a technology that is superior to those products that we are
currently developing; and ProPhotonix's ability to capitalize on its significant research and development efforts by successfully
marketing those products that the Company develops. Forward-looking statements represent management's current expectations and
are inherently uncertain. All Company, brand, and product names are trademarks or registered trademarks of their respective
holders. ProPhotonix undertakes no duty to update any of these forward-looking statements.
This information is provided by RNS
The company news service from the London Stock Exchange